These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 34922740)

  • 21. The role and impact of SNPs in pharmacogenomics and personalized medicine.
    Laing RE; Hess P; Shen Y; Wang J; Hu SX
    Curr Drug Metab; 2011 Jun; 12(5):460-86. PubMed ID: 21453271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [PHARMACOGENOMICS AND PERSONALIZED MEDICINE: TOWARDS A SYSTEMATIC GENOMIC SCREENING?].
    Dideberg V; Segers K; Koopmansch B; Lambert F; Bours V
    Rev Med Liege; 2015; 70(5-6):251-6. PubMed ID: 26285448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Approaches to the discovery of pharmacogenomic markers in oncology: 2000-2010-2020.
    Huang RS; Dolan ME
    Pharmacogenomics; 2010 Apr; 11(4):471-4. PubMed ID: 20350124
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Deep learning of pharmacogenomics resources: moving towards precision oncology.
    Chiu YC; Chen HH; Gorthi A; Mostavi M; Zheng S; Huang Y; Chen Y
    Brief Bioinform; 2020 Dec; 21(6):2066-2083. PubMed ID: 31813953
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Deciphering next-generation pharmacogenomics: an information technology perspective.
    Potamias G; Lakiotaki K; Katsila T; Lee MT; Topouzis S; Cooper DN; Patrinos GP
    Open Biol; 2014 Jul; 4(7):. PubMed ID: 25030607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unveiling the guidance heterogeneity for genome-informed drug treatment interventions among regulatory bodies and research consortia.
    Koutsilieri S; Tzioufa F; Sismanoglou DC; Patrinos GP
    Pharmacol Res; 2020 Mar; 153():104590. PubMed ID: 31830522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modern developments in germline pharmacogenomics for oncology prescribing.
    Reizine NM; O'Donnell PH
    CA Cancer J Clin; 2022 Jul; 72(4):315-332. PubMed ID: 35302652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tools in Pharmacogenomics Biomarker Identification for Cancer Patients.
    Scionti F; Di Martino MT; Caracciolo D; Pensabene L; Tagliaferri P; Arbitrio M
    Methods Mol Biol; 2022; 2401():1-12. PubMed ID: 34902118
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The emerging roles of NGS in clinical oncology and personalized medicine.
    Hussen BM; Abdullah ST; Salihi A; Sabir DK; Sidiq KR; Rasul MF; Hidayat HJ; Ghafouri-Fard S; Taheri M; Jamali E
    Pathol Res Pract; 2022 Feb; 230():153760. PubMed ID: 35033746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pharmacogenomics in the age of personalized medicine.
    Dickmann LJ; Ware JA
    Drug Discov Today Technol; 2016; 21-22():11-16. PubMed ID: 27978982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pharmacogenomics in the era of next generation sequencing - from byte to bedside.
    Russell LE; Zhou Y; Almousa AA; Sodhi JK; Nwabufo CK; Lauschke VM
    Drug Metab Rev; 2021 May; 53(2):253-278. PubMed ID: 33820459
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacogenomics and Personalized Medicine.
    Cecchin E; Stocco G
    Genes (Basel); 2020 Jun; 11(6):. PubMed ID: 32580376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Molecular Targets in Advanced Therapeutics of Cancers: The Role of Pharmacogenetics.
    Abubakar MB; Gan SH
    Oncology; 2016; 91(1):3-12. PubMed ID: 27233906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacogenetics and pharmacogenomics in oncology therapeutic antibody development.
    Yan L; Beckman R
    Biotechniques; 2005 Oct; 39(10 Suppl):S565-8. PubMed ID: 18957038
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision Medicine in Pediatric Oncology.
    Vo KT; Parsons DW; Seibel NL
    Surg Oncol Clin N Am; 2020 Jan; 29(1):63-72. PubMed ID: 31757314
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Translational approach for pharmacogenomics and personalized medicine].
    Zhang W; Zhou HH
    Yao Xue Xue Bao; 2011 Jan; 46(1):1-5. PubMed ID: 21465801
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacogenetics in clinical practice: how far have we come and where are we going?
    Johnson JA
    Pharmacogenomics; 2013 May; 14(7):835-43. PubMed ID: 23651030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Impact of Pharmacogenomics in Personalized Medicine.
    Singh DB
    Adv Biochem Eng Biotechnol; 2020; 171():369-394. PubMed ID: 31485703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacogenomics, precision medicine, and implications for anesthesia care.
    Kaye AD; Mahakian T; Kaye AJ; Pham AA; Hart BM; Gennuso S; Cornett EM; Gabriel RA; Urman RD
    Best Pract Res Clin Anaesthesiol; 2018 Jun; 32(2):61-81. PubMed ID: 30322465
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enabling personalized cancer medicine decisions: The challenging pharmacological approach of PBPK models for nanomedicine and pharmacogenomics (Review).
    Vizirianakis IS; Mystridis GA; Avgoustakis K; Fatouros DG; Spanakis M
    Oncol Rep; 2016 Apr; 35(4):1891-904. PubMed ID: 26781205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.